[
  {
    "ts": null,
    "headline": "Zimmer Biomet Q3 Earnings To Highlight Innovation And Growth - Why I Think It's A Buy",
    "summary": "Zimmer Biomet is undervalued despite recent underperformance, backed by innovation, acquisitions, and strong cash flow. Learn why ZBH stock is a buy.",
    "url": "https://finnhub.io/api/news?id=c2656d7f02fc9c1f858645d53240593a0c9153a225cf3280e5d44d586ff9a816",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760243047,
      "headline": "Zimmer Biomet Q3 Earnings To Highlight Innovation And Growth - Why I Think It's A Buy",
      "id": 137056846,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2199586292/image_2199586292.jpg?io=getty-c-w1536",
      "related": "ZBH",
      "source": "SeekingAlpha",
      "summary": "Zimmer Biomet is undervalued despite recent underperformance, backed by innovation, acquisitions, and strong cash flow. Learn why ZBH stock is a buy.",
      "url": "https://finnhub.io/api/news?id=c2656d7f02fc9c1f858645d53240593a0c9153a225cf3280e5d44d586ff9a816"
    }
  }
]